Late Breaking Abstracts

Presentation Title	Presenter
Randomized Controlled Multicenter Trial Evaluating The Efficacy And Safety Of Albumin Dialysis With Mars In Patients With Fulminant And Subfulminant Hepatic Failure	Faouzi Saliba
Randomized, Double-blind Controlled Trial Of High-dose Ursodeoxycholic Acid (UCDA) For Primary Sclerosing Cholangitis (PSC)	Keith Lindor
Terlipressin Given As Continuous Intravenous Infusion Is The More Suitable Schedule For The Treatment Of Type 1 Hepatorenal Syndrome (HRS) In Patients With Cirrhosis: Results Of A Controlled Clinical Study	Paolo Angeli
SAME Improves Early Viral Kinetics And Interferon Stimulated Gene Induction When Added To Peginterferon And Ribavirin Therapy For Previous Hepatitis C Non-Responders	Jordan J. Feld
Metformin With Peginterferon Alfa-2A And Ribavirin In The Treament Of Naive Genotype 1 Chronic Hepatitis C Patients With Insulin Resistance (TRIC-1): Final Results Of A Randomized And Double-blind Trial	Manuel Romero-Gomez